Valuation: MindMaze Therapeutics Holding SA

Market Cap 2.36Cr 2.83Cr 2.53Cr 2.14Cr 4.04Cr 273.02Cr 4.07Cr 28Cr 11Cr 139.34Cr 11Cr 10Cr 447.9Cr P/E 2026 *
-3.47x
P/E 2027 * 0.99x
Enterprise Value 1.51Cr 1.82Cr 1.63Cr 1.38Cr 2.6Cr 175.46Cr 2.61Cr 18Cr 7.12Cr 90Cr 6.84Cr 6.69Cr 287.85Cr EV / Sales 2026 *
2.57x
EV / Sales 2027 * 0.1x
Free-Float
34.81%
Yield 2026 *
-
Yield 2027 * -
1 day-1.15%
1 week-5.73%
Current month-6.24%
1 month-15.01%
3 months-31.75%
6 months-54.09%
Current year-92.73%
1 week 0.14
Extreme 0.1356
0.15
1 month 0.14
Extreme 0.1356
0.18
Current year 0.14
Extreme 0.1356
1.87
1 year 0.14
Extreme 0.1356
2.92
3 years 0.14
Extreme 0.1356
2.92
5 years 0.14
Extreme 0.1356
2.92
10 years 0.14
Extreme 0.1356
2.92
Date Insider Type Main position Quantity % Market Cap. Importance
19/12/25 Sell 1,40,000 0.0908%
19/12/25 Sell 52,162 0.0338%
19/12/25 Sell 2,81,968 0.1830%
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%-5.73% - - 2.84Cr
+4.16%+3.04%+49.37%+94.17% 7.42TCr
-0.37%-3.81%+19.51%+78.12% 5.74TCr
+1.63%-1.61%+3.16%+36.89% 4.76TCr
-1.02%+1.44%+339.32%+710.11% 4.43TCr
+2.00%-2.80%+28.47%+33.15% 4.25TCr
+0.49%-2.14%+4.24%+110.42% 4.07TCr
-0.54%+2.93%+9.31%+54.06% 3.1TCr
+1.56%+4.53%+31.34%+26.92% 2.85TCr
+0.06%-2.45%-8.09%-12.02% 2.43TCr
Average +0.66%-1.15%+52.96%+125.76% 3.91TCr
Weighted average by Cap. +1.14%-0.84%+57.17%+135.02%

Financials

2026 *2027 *
Net sales 59L 70.99L 63.33L 53.69L 1.01Cr 68Cr 1.02Cr 7.13Cr 2.77Cr 35Cr 2.66Cr 2.61Cr 112.16Cr 4.32Cr 5.2Cr 4.64Cr 3.93Cr 7.4Cr 500.59Cr 7.46Cr 52Cr 20Cr 255.49Cr 20Cr 19Cr 821.24Cr
Net income -78.11L -93.98L -83.84L -71.08L -1.34Cr -91Cr -1.35Cr -9.44Cr -3.67Cr -46Cr -3.53Cr -3.45Cr -148.49Cr 2.48Cr 2.99Cr 2.66Cr 2.26Cr 4.25Cr 287.69Cr 4.29Cr 30Cr 12Cr 146.83Cr 11Cr 11Cr 471.96Cr
Net Debt -84.19L -1.01Cr -90.37L -76.62L -1.44Cr -98Cr -1.45Cr -10Cr -3.96Cr -50Cr -3.8Cr -3.72Cr -160.05Cr -1.93Cr -2.32Cr -2.07Cr -1.75Cr -3.3Cr -223.28Cr -3.33Cr -23Cr -9.06Cr -113.96Cr -8.7Cr -8.52Cr -366.31Cr
Logo MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.
Employees
-
Date Price Change Volume
05/26/05 CHF 0.1382 -0.29% 9,57,049
02/26/02 CHF 0.1386 -4.94% 10,39,754
01/26/01 CHF 0.1458 -1.09% 14,20,572
30/26/30 CHF 0.1474 -0.27% 6,50,630
29/26/29 CHF 0.1478 +0.82% 6,61,570
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise